PUBLISHER: The Business Research Company | PRODUCT CODE: 1682060
PUBLISHER: The Business Research Company | PRODUCT CODE: 1682060
Chronic venous occlusion refers to the prolonged blockage or obstruction of veins, commonly occurring in the legs or arms, which can hinder blood flow and result in various health issues such as swelling, pain, and skin changes. Treatment aims to alleviate symptoms, slow down the disease's progression, and prevent complications.
The primary categories of products within chronic venous occlusion treatment include devices and drugs. Devices encompass instruments, apparatuses, machines, or implants utilized for prevention, diagnosis, or treatment. In chronic venous occlusion treatment, devices play a crucial role in restoring proper blood flow and enhancing overall venous health, contributing to the success of treatment outcomes. These applications span various conditions, including varicose veins, venous stasis ulcers, edema, deep vein thrombosis, and others. They are utilized by hospitals, clinics, ambulatory surgery centers, trauma centers, and other healthcare facilities.
The chronic venous occlusions treatment market research report is one of a series of new reports from The Business Research Company that provides chronic venous treatment market statistics, including chronic venous occlusions treatment industry global market size, regional shares, competitors with a chronic venous occlusions treatment market share, detailed chronic venous occlusions treatment market segments, market trends and opportunities, and any further data you may need to thrive in the chronic venous occlusions treatment industry. This chronic venous occlusions treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The chronic venous occlusions treatment market size has grown strongly in recent years. It will grow from $6.7 billion in 2024 to $7.19 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to investments in treatment innovation, rise in venous disorder prevalence, awareness and diagnosis improvement, clinical trials and research initiatives, improved patient outcomes and quality of life.
The chronic venous occlusions treatment market size is expected to see strong growth in the next few years. It will grow to $9.32 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to rise in venous disorders awareness, rising demand for minimally invasive procedures, ageing population dynamics, advancements in endovascular therapies, focus on patient-centric care. Major trends in the forecast period include advancements in minimally invasive procedures, technological innovations in interventional radiology, focus on endovascular therapies, growing prevalence of venous disorders, rise in aging population.
The anticipated rise in obesity cases is set to drive the growth of the chronic venous occlusion treatment market in the future. Obesity, characterized by an excessive accumulation of body fat leading to a body mass index (BMI) of 30 or higher, can be associated with symptoms such as edema and skin changes. Chronic venous occlusion treatment plays a crucial role in managing these symptoms by improving blood flow and reducing inflammation, contributing to effective obesity management. As reported in March 2023 by the World Heart Federation, around 2.3 billion adults and children globally were either obese or overweight. With the current obesity trend, it is projected that the number of individuals with obesity will reach 2.7 billion by 2025. Therefore, the increasing prevalence of obesity is a key factor propelling the growth of the chronic venous occlusion treatment market.
The growing adoption of minimally invasive procedures is expected to drive the growth of the chronic venous occlusions treatment market. Minimally invasive procedures involve medical and surgical techniques performed through small incisions or natural body openings, as opposed to large surgical cuts. These techniques are linked to a lower risk of complications such as infections, bleeding, and scarring. Since patients with chronic venous occlusions often have additional health concerns, minimizing the risk of complications is vital for their overall health. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a UK-based professional organization for certified plastic surgeons, reported that in 2023, the total number of both surgical and non-surgical procedures grew by 3.4%, reaching 34.9 million. Liposuction emerged as the most popular surgical procedure among women, surpassing breast augmentation, with 1.8 million procedures performed-a 29% increase since 2021. Therefore, the rising adoption of minimally invasive procedures is fueling the growth of the chronic venous occlusion treatment market.
Key players in the chronic venous occlusion treatment market are concentrating on developing innovative solutions, such as implantable medical devices designed to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI). An implantable medical device is a device surgically placed inside the body for long-term use, typically for diagnosing, treating, or monitoring medical conditions. For example, in June 2024, Koninklijke Philips N.V. (Philips), a technology company based in the Netherlands, launched the Duo Venous Stent System, an implantable medical device. The Duo Venous Stent System features a dual-layer design that enhances flexibility and radial strength for optimal vein support. Its advanced coating improves biocompatibility and reduces the risk of thrombosis, while the precise delivery system ensures accurate placement in challenging anatomical conditions.
In January 2022, Koninklijke Philips N.V. (Philips) acquired Vesper Medical, a biotechnology company based in Canada, for an undisclosed amount. This acquisition strengthens Philips' portfolio in vascular health solutions, enabling the development of advanced treatments for venous diseases. The move positions Philips to capitalize on innovative technologies, which could increase its market share and enhance patient outcomes in the expanding vascular intervention market. Vesper Medical specializes in the treatment of deep venous disease.
Major companies operating in the chronic venous occlusions treatment market report are Cardinal Health Inc., Bayer AG, Sanofi S.A., 3M Company, Bristol-Myers Squibb Company, Medtronic PLC, Becton, Dickinson and Company (BD), Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Ethicon Inc., Philips Medical Systems, Teleflex Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., Integer Holdings Corporation, Penumbra Inc., Inari Medical, Argon Medical Devices Inc., AngioDynamics Inc., Rontis Corporation, Endologix, Richard Wolf GmbH, SIGVARIS AG, enVVeno Medical Corporation, LimFlow SA
North America was the largest region in the chronic venous occlusions treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic venous occlusions treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the chronic venous occlusions treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The chronic venous occlusion treatment market consists of revenues earned by entities by providing services such as magnetic resonance imaging (MRI), fluoroscopy, computerized tomography (CT) scanning, anticoagulation therapy, and surgical intervention. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic venous occlusion treatment market also includes sales of anticoagulants, thrombolytic agents, pain relievers, and anti-inflammatory drugs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Chronic Venous Occlusions Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on chronic venous occlusions treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for chronic venous occlusions treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic venous occlusions treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.